Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (71-80 of 304) with videos related to

Pageof 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
Haplotypes of FcγRIIa and FcγRIIIb polymorphic variants influence IgG-mediated responses in neutrophilsJoris van der Heijden, Sietse Nagelkerke, Xiwen Zhao, et al.
Vox Sanguinis|July 4, 2023
Quality assessment and harmonization of laboratories across Europe for multiple SARS-CoV-2 serology assaysMaurice Steenhuis, Elise Wouters, Hubert Schrezenmeier, et al.
Plos One|September 25, 2014
On the perplexingly low rate of transport of IgG2 across the human placentaHelga K Einarsdottir, Nigel M Stapleton, Sicco Scherjon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 23, 2017
Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related DiseaseEmma L Culver, Ross Sadler, Adrian C Bateman, et al.
Journal of Clinical Immunology|May 25, 2012
IgG4 production against adalimumab during long term treatment of RA patientsPauline A van Schouwenburg, Charlotte L Krieckaert, Michael Nurmohamed, et al.
Journal of Molecular Biology|November 12, 2013
Structural determinants of unique properties of human IgG4-FcAnna M Davies, Theo Rispens, Pleuni Ooijevaar-de Heer, et al.
Annals of the Rheumatic Diseases|September 24, 2017
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trialMerel J l'Ami, Charlotte Lm Krieckaert, Michael T Nurmohamed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2017
The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosingZoé LE van Kempen, Cyra E Leurs, Birgit I Witte, et al.
Annals of the Rheumatic Diseases|May 11, 2019
Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte <i>et al</i>Merel J l'Ami, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
Analytical Biochemistry|March 19, 2013
Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatographyTheo Rispens, Pleuni Ooijevaar-de Heer, Ninotska I L Derksen, et al.
Pageof 31

Showing results (71-80 of 304) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
Haplotypes of FcγRIIa and FcγRIIIb polymorphic variants influence IgG-mediated responses in neutrophilsJoris van der Heijden, Sietse Nagelkerke, Xiwen Zhao, et al.
Vox Sanguinis|July 4, 2023
Quality assessment and harmonization of laboratories across Europe for multiple SARS-CoV-2 serology assaysMaurice Steenhuis, Elise Wouters, Hubert Schrezenmeier, et al.
Plos One|September 25, 2014
On the perplexingly low rate of transport of IgG2 across the human placentaHelga K Einarsdottir, Nigel M Stapleton, Sicco Scherjon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 23, 2017
Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related DiseaseEmma L Culver, Ross Sadler, Adrian C Bateman, et al.
Journal of Clinical Immunology|May 25, 2012
IgG4 production against adalimumab during long term treatment of RA patientsPauline A van Schouwenburg, Charlotte L Krieckaert, Michael Nurmohamed, et al.
Journal of Molecular Biology|November 12, 2013
Structural determinants of unique properties of human IgG4-FcAnna M Davies, Theo Rispens, Pleuni Ooijevaar-de Heer, et al.
Annals of the Rheumatic Diseases|September 24, 2017
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trialMerel J l'Ami, Charlotte Lm Krieckaert, Michael T Nurmohamed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2017
The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosingZoé LE van Kempen, Cyra E Leurs, Birgit I Witte, et al.
Annals of the Rheumatic Diseases|May 11, 2019
Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte <i>et al</i>Merel J l'Ami, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
Analytical Biochemistry|March 19, 2013
Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatographyTheo Rispens, Pleuni Ooijevaar-de Heer, Ninotska I L Derksen, et al.
Pageof 31